Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.
作者信息
Kessler Chiara, Stricker Hans, Demundo Daniela, Elzi Luigia, Monotti Rita, Bianchi Giorgia, Llamas Michael, Spinedi Luca, Rossi Davide, Chiesa Alessandro Felice, Pagnamenta Alberto, Conti Marco, Casso Gabriele, Stoira Elisa, Valenti Elisa, Colucci Giuseppe, Stussi Georg, Gerber Bernhard, Previsdomini Marco
机构信息
Clinic of Hematology, Oncology Institute of Southern Switzerland, 6500, Bellinzona, Switzerland.
Department of Angiology, Ospedale La Carità, Locarno, Switzerland.
出版信息
J Thromb Thrombolysis. 2020 Nov;50(4):833-836. doi: 10.1007/s11239-020-02244-y.
Abstract
摘要
相似文献
1
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.
J Thromb Thrombolysis. 2020 Nov;50(4):833-836. doi: 10.1007/s11239-020-02244-y.
2
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.
J Thromb Thrombolysis. 2020 Nov;50(4):795-798. doi: 10.1007/s11239-020-02227-z. Epub 2020 Jul 16.
3
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.
J Thromb Thrombolysis. 2020 Nov;50(4):799-808. doi: 10.1007/s11239-020-02231-3.
4
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
J Thromb Thrombolysis. 2020 Nov;50(4):814-821. doi: 10.1007/s11239-020-02235-z.
5
[What I talk about when I talk about COVID-19].
Laeknabladid. 2020 Sep;106(9):395. doi: 10.17992/lbl.2020.09.594.
6
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
J Thromb Thrombolysis. 2020 Nov;50(4):1012-1014. doi: 10.1007/s11239-020-02248-8. Epub 2020 Aug 11.
7
Effect of Gastrointestinal Symptoms in Patients With COVID-19.
Gastroenterology. 2020 Jun;158(8):2294-2297. doi: 10.1053/j.gastro.2020.03.020. Epub 2020 Mar 19.
8
COVID-19 and the Forgotten Majority.
High Blood Press Cardiovasc Prev. 2020 Oct;27(5):339. doi: 10.1007/s40292-020-00407-9. Epub 2020 Aug 29.
9
In Defense of Our Patients: Indirect Negative Neurological Consequences of SARS-CoV-2 in the New York Epicenter.
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105127. doi: 10.1016/j.jstrokecerebrovasdis.2020.105127. Epub 2020 Jul 10.
10
Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
J Thromb Thrombolysis. 2020 Jul;50(1):221-222. doi: 10.1007/s11239-020-02131-6.
引用本文的文献
1
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑19.
Thromb J. 2024 Jan 4;22(1):5. doi: 10.1186/s12959-023-00572-6.
2
COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.
Res Pract Thromb Haemost. 2023 Sep 20;7(7):102206. doi: 10.1016/j.rpth.2023.102206. eCollection 2023 Oct.
3
Spontaneous bleeding in COVID-19: A retrospective experience of an Italian COVID-19 hospital.
SA J Radiol. 2022 Oct 31;26(1):2509. doi: 10.4102/sajr.v26i1.2509. eCollection 2022.
4
Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies.
TH Open. 2022 Oct 19;6(4):e323-e334. doi: 10.1055/a-1930-6492. eCollection 2022 Oct.
5
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study.
Thromb J. 2022 Sep 20;20(1):53. doi: 10.1186/s12959-022-00414-x.
6
Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population-Bleeding Risk Factors in COVID-19 Patients.
J Clin Med. 2022 May 13;11(10):2754. doi: 10.3390/jcm11102754.
7
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.
Med Intensiva. 2023 Jan;47(1):1-8. doi: 10.1016/j.medin.2021.07.004. Epub 2021 Jul 30.
8
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study.
Res Pract Thromb Haemost. 2021 May 7;5(4):e12521. doi: 10.1002/rth2.12521. eCollection 2021 May.
9
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis.
Front Cardiovasc Med. 2021 Jan 8;7:598846. doi: 10.3389/fcvm.2020.598846. eCollection 2020.
本文引用的文献
1
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
2
Coagulation abnormalities and thrombosis in patients with COVID-19.
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
3
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
4
Incidence of venous thromboembolism in hospitalized patients with COVID-19.
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
5
COVID-19 and its implications for thrombosis and anticoagulation.
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
6
Endothelial cell infection and endotheliitis in COVID-19.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
7
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
8
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
Zotero 插件